Reunion Neuroscience and MPM BioImpact announce the completion of the previously announced plan of arrangement effective today, whereby MPM acquired Reunion in an all-cash transaction valued at approximately US$13.1 million by way of a court-approved plan of arrangement under Section 192 of the Canada Business Corporations Act. Pursuant to the terms and conditions of a definitive arrangement agreement entered into by Reunion and affiliates of MPM on May 31, 2023, all holders of outstanding common shares of Reunion are entitled to receive US$1.12 in cash for each Share held immediately prior to the effective time of the Arrangement.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on REUN:
- Reunion Neuroscience Inc. and MPM BioImpact Announce Completion of Plan of Arrangement
- Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement
- Reunion Neuroscience Inc. Shareholders Approve Proposed Plan of Arrangement
- Reunion Neuroscience shareholders approve proposed plan of arrangement
- Reunion Neuroscience Reports Fiscal Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update